Skip to content

Eccentric Resistance Training With Blood Flow Restriction on Muscle Function

Effects of Blood Flow Restriction During Multiple-joint Eccentric Resistance Training on Muscle Morphology and Function of the Lower Body.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04977804
Enrollment
0
Registered
2021-07-27
Start date
2024-03-30
Completion date
2025-12-01
Last updated
2023-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Flow Restriction

Keywords

resistance training, muscle function, quadriceps, eccentric strength, vertical jump, muscle quality, muscle hypertrophy, eccentric training

Brief summary

The study will determine the effects of adding blood flow restriction to eccentric training to assess whether this increases the improvements of muscle strength and size.

Detailed description

Subjects will be randomly assigned to two groups: an eccentric only resistance training group or an eccentric training plus blood flow restriction group. Subjects will train at a moderately low intensity on a multiple-joint eccentric device. Those in the blood flow restriction will wear blood flow restriction cuffs on their upper thighs to reduce blood flow during the brief protocol. The training session will occur twice per week and will last \ 5 minutes, including a one minute warm up, a one minute cool down and a three minute workout phase. The training program will last 7 weeks. Testing will be conducted at baseline (following a one session familiarization), 4 weeks and after the end of the 7 week training period. Assessments will focus on muscle strength, function, and morphology (size).

Interventions

OTHERExercise

The interventions are a form or exercise, specifically resistance exercise.

OTHEREccentric plus blood-flow restriction

Eccentric plus blood-flow restriction

Sponsors

Utah State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Masking description

The person assessing the outcome measures will be blinded to the group designation of the subjects.

Intervention model description

Two group, randomized parallel group design.

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-30 years of age * currently engaged in some form of resistance training between 1-3 times per week * must have been training aerobically, but no more than 3 hours a week for the past six months

Exclusion criteria

* Must not have had any surgery of the lower limbs within the past 1 year period * Must not have any neuromuscular disorder (e.g., Muscular dystrophy etc.) * \< 76 inches tall (in order to fit on the training machine) * Maximal strength of \< 725 lbs for the eccentric training device * If any of the subjects are pregnant or plan to be pregnant in the duration of the protocol. For those randomized to the BFR group, if any of the subject's thighs are too large for the BFR cuffs (greater than 68 cm).

Design outcomes

Primary

MeasureTime frameDescription
Eccentron maximal muscle strength7 weeksEccentric muscle strength will be assessed via Eccentron (BTE Technologies, Inc., USA), an seated isokinetic dynamometer.
Local muscle hypertrophy7 weeksMuscle size changes of the quadriceps muscle measured an ultrasound device (GE NextGen LOGIQ, Tampa, Florida, USA).
Muscle mass7 weeksdual energy x-ray absorptiometry device (DEXA) the Hologic Horizon W Dual X-ray absorptiometry (Hologic Canada ULC, Mississauga, ON, Canada) will be used to assess appendicular (lower body) mean mass.
Muscle function7 weeksVertical jump height will assess 3 maximal countermovement attempts on a jump mat (Just Jump Technologies, Huntsville, AL, USA) that measures jump height based on flight time.

Secondary

MeasureTime frameDescription
Muscle soreness7 weekslocal muscle soreness will be assessed throughout the duration of the intervention period using a Wagner force algometer.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026